Related Experiment Video
Updated: Apr 30, 2026

Murine Isolated Heart Model of Myocardial Stunning Associated with Cardioplegic Arrest
Published on: August 6, 2015
Metoclopramide-induced cardiac arrest.
Martha M Rumore1, Spencer Evan Lee2, Steven Wang2
1Drug Information, New York -Presbyterian Hospital; ; Pharmacy & Health Outcomes, Touro College of Pharmacy, New York;
Intravenous metoclopramide can cause cardiac arrest, even in patients without known heart conditions. Clinicians should monitor patients for serious cardiac adverse drug reactions (ADRs) when administering this medication.
Area of Science:
- Cardiology
- Pharmacology
- Clinical Medicine
Background:
- Metoclopramide, a dopamine receptor antagonist, is commonly used for gastrointestinal motility disorders.
- Adverse drug reactions (ADRs) associated with metoclopramide are not fully characterized, particularly severe cardiac events.
- The potential for metoclopramide to induce cardiac arrest is not widely recognized or listed in its prescribing information.
Purpose of the Study:
- To report a case of cardiac arrest following intravenous metoclopramide administration.
- To review existing literature on metoclopramide-associated cardiac events.
- To raise awareness among clinicians regarding potential severe cardiac ADRs of metoclopramide.
Main Methods:
- Case report of a patient experiencing cardiac arrest after IV metoclopramide.
- Literature search for similar cases of cardiac arrest, bradycardia, and arrhythmias associated with metoclopramide.
- Analysis of the patient's clinical presentation, ECG findings, and response to treatment.
- Assessment of the potential causality using the Naranjo scale.
Main Results:
- A 62-year-old female developed cardiac arrest, including bradycardia and asystole, within one minute of receiving IV metoclopramide.
- The patient experienced subsequent cardiac dysrhythmias, including supraventricular tachycardia and atrial fibrillation.
- Literature review identified seven previous cases of cardiac arrest and one of sinus arrest linked to metoclopramide.
- Coronary artery disease was identified as a potential risk factor in this case; the reaction is not dose-dependent but may be route-related (IV).
Conclusions:
- Intravenous metoclopramide administration can precipitate severe cardiac events, including cardiac arrest.
- The prescribing information for metoclopramide does not adequately warn of this rare but serious ADR.
- Clinicians must exercise vigilance, monitor patients closely for cardiac dysrhythmias, and report suspected cases of metoclopramide-induced cardiac arrest.
More Related Videos
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Related Concept Videos
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Heart Failure Drugs: Inotropic Agents
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Cardiopulmonary Resuscitation IV: Pharmacological Management